Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
What this study shows
Induced autophagy cleared toxic clumped proteins and improved symptoms in fly (rapamycin) and mouse (the rapalog CCI-779) models of Huntington's disease.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Drosophila and mouse models of Huntington's disease); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Drosophila and mouse models of Huntington's disease |
| Journal | Nature Genetics |
| Year | 2004 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/ng1362 · PMID 15146184 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Rapamycin (mTOR inhibition) |
| Target | mTOR / autophagy |
| Model | Drosophila and mouse Huntington's disease models |
| Effect | mTOR inhibition induces autophagy and reduces polyglutamine toxicity in Huntington's disease models |
In the Atlas
Related topics
More studies on this topic
- Rapamycin alleviates toxicity of different aggregate-prone proteins (2006)
- Molecular switches of SQSTM1: the impact of post-translational modifications on autophagy and neurodegeneration (2026)
- Strengthening Muscle for Healthy Ageing: Innovative Treatments for Sarcopenia (2026)
- Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster (2010)
Was this page useful?
Thank you. Your answer was counted anonymously.